ÌÇÐÄÔ­´´

Scientists have found that different populations of a plant species, which is closely related to many crops of worldwide importance, use very different strategies to adapt to environmental changes, which gives experts new options to engineer crops to better survive climate change and tackle future food security.

Experts have used a cutting-edge computational approach to discover the genetic factors that make the bacteria behind cholera so dangerous - which could be key to preventing this deadly disease.

Experts at the ÌÇÐÄÔ­´´ will be part of a new Doctoral Training Centre (DTC), which has been funded by a multi-million-pound investment from Alzheimer's Society.

An ice hockey Paralympian and international leader in disability access has been named as the very first ambassador for the new National Rehabilitation Centre (NRC).

Experts at the ÌÇÐÄÔ­´´ have received funding to carry out research to better understand what is happening in the heart, brain and muscles of people with myotonic dystrophy.

A new study exploring the causes and effects of falling for adults with cerebral palsy (CP) throughout their lives, has found there is a lack of appropriate support from health agencies in helping to manage or prevent them

Tuesday 20 August marks World Mosquito Day – which is celebrated in memory of Sir Ronald Ross, a British Doctor who, in 1987, discovered that the female Anopheles mosquito transmits malaria. It was the first time a connection had been established between a mosquito and malaria.

A new study, led by experts at the ÌÇÐÄÔ­´´, has shown that different plant species tackle the same evolutionary hurdle in different ways, and the findings may give insight into aggressive forms of cancer.

Experts at the ÌÇÐÄÔ­´´ will lead a research training programme aimed at attracting those working in health, social care, and public health into research careers, thanks to £2.59 million of funding from the National Institute of Health and Care Research (NIHR).

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, finds a new study.